Cases 11 - 20 of 915
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00050
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
WILLIAMS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22452
Plaintiff:
BOBBY WILLIAMS
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN, N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2023cv01015
Plaintiff:
Heron Therapeutics, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MCNALL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv21327
Plaintiff:
MARK MCNALL
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HART v. MYLAN LABORATORIES LTD. et al
as 1:2023cv14068
Plaintiff:
FRANKLIN W. HART
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WOJNICKI v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04496
Plaintiff:
JAMES WOJNICKI
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BISHOP v. MYLAN LABORATORIES, LTD. et al
as 1:2023cv04317
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
MARY R. BISHOP
Defendant:
MYLAN LABORATORIES, LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff:
STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
EATON et al v. MYLAN LABORATORIES LTD. et al
as 1:2023cv04114
Plaintiff:
GERALD LEE EATON and NANCY P. EATON
Defendant:
MYLAN LABORATORIES, LTD., MYLAN N.V., MYLAN PHARMACEUTICALS, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
